Track Real Time Price

Famotidine Prices Witnessed Significant Decline Across Global Markets in Q1 2026 According to ChemAnalyst, Famotidine Prices recorded a notable decline during the first quarter of 2026 due to ongoing oversupply conditions, sluggish pharmaceutical procurement activity, and aggressive supplier pricing strategies across major regions. Famotidine, a widely used histamine H2-receptor antagonist employed in the treatment of ulcers, gastroesophageal reflux disease (GERD), and other acid-related gastrointestinal disorders, remained under sustained pricing pressure amid weaker post-tender demand and growing inventory accumulation in the global market. The Famotidine prices declined considerably across the Asia-Pacific, North American, and European markets during the first quarter of 2026. The market was influenced by ample import supplies, lower freight charges, and subdued purchasing sentiment among pharmaceutical manufacturers and distributors. Nevertheless, short-term logistical disruptions...

Introduction to Famotidine Market Dynamics Famotidine, a widely used active pharmaceutical ingredient (API) belonging to the H2 receptor antagonist class, plays a critical role in the treatment of acid-related gastrointestinal disorders such as ulcers, GERD, and Zollinger-Ellison syndrome. Over the years, the global demand for Famotidine has remained steady, supported by its inclusion in essential drug lists and widespread over-the-counter usage. In 2025, Famotidine prices  have demonstrated varied trends across key regions, influenced by fluctuations in production costs, energy prices, macroeconomic indicators, and supply-demand dynamics. This article provides a detailed analysis of Famotidine price trends in  North America, Asia-Pacific (APAC), and Europe , along with insights into the factors shaping the market. Key Factors Influencing Famotidine Prices Before diving into regional price trends, it is essential to understand the primary factors driving  Famotidine price...

Introduction to the Famotidine Market Famotidine, a widely used histamine-2 (H2) receptor antagonist, plays a critical role in the pharmaceutical industry for treating conditions such as acid reflux, peptic ulcers, and gastroesophageal reflux disease (GERD). As a key active pharmaceutical ingredient (API), its pricing dynamics are influenced by multiple factors, including raw material costs, energy prices, production efficiency, regulatory frameworks, and global demand-supply balances. The  Famotidine Prices  trend in Q3 2025 presented a mixed outlook across major global regions, with North America witnessing price increases, Asia-Pacific experiencing declines, and Europe maintaining relative stability. This article provides a comprehensive analysis of these regional price movements, underlying market drivers, and future outlook. Global Overview of Famotidine Price Trends During Q3 2025, the global Famotidine market exhibited divergent pricing patterns due to regional economic...